GRAIL, Inc. Announces $325.0 Million Private Placement Financing
MENLO PARK, Calif., Oct. 20, 2025 /PRNewswire/ — GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured,... Read more.
Global Times: China’s digital trade channels empower BRI partners, Global South’s integration into global value chains
BEIJING, Oct. 20, 2025 /PRNewswire/ — Most products – domestic or from abroad – that you bought online would come to your home in just a few days... Read more.
Dubai advances position as Middle East, Africa and South Asia’s leading global financial centre
DUBAI, UAE, Oct. 20, 2025 /PRNewswire/ — Dubai continues to advance its position as the Middle East, Africa and South Asia’s (MEASA) leading global financial... Read more.
Groundbreaking Study in the Journal of Clinical Investigation Advances Cell Therapy for Huntington’s Disease Treatment
SHANGHAI, Oct. 20, 2025 /PRNewswire/ — The research team led by Dr. Yuejun Chen, founder of UniXell Biotech, published online an article titled “3D-Cultured... Read more.
IBM and Groq Partner to Accelerate Enterprise AI Deployment with Speed and Scale
Partnership aims to deliver faster agentic AI capabilities through IBM watsonx Orchestrate and Groq technology, enabling enterprise clients to take immediate action... Read more.
Taylor Morrison Earns Great Place To Work Certification™
America’s Most Trusted® Home Builder receives recognition for workplace culture and employee experience SCOTTSDALE, Ariz. , Oct. 20, 2025 /PRNewswire/... Read more.
Battery Recycling Market to Reach $77.1 billion, Globally, by 2034 at 11.2% CAGR: Allied Market Research
WILMINGTON, Del., Oct. 20, 2025 /PRNewswire/ — Allied Market Research published a report, titled, “Battery Recycling Market by Chemistry (Lead-Acid Based... Read more.
ORVANA STRENGTHENS POSITION IN ITS TAGUAS PROPERTY IN ARGENTINA BY REACQUIRING 1% NSR INTEREST
TORONTO, Oct. 20, 2025 /PRNewswire/ – Orvana Minerals Corp. (TSX: ORV) (the “Company” or “Orvana”) is pleased to announce that it... Read more.
IDEAYA Biosciences Reports Positive Median Overall Survival Data from Phase 2 Trial of the Darovasertib and Crizotinib Combination in First-line Metastatic Uveal Melanoma at the 2025 Society for Melanoma Research Congress
Combination demonstrated median overall survival (OS) of 21.1 months, compared to reported historical mOS of approximately 12 months in published meta-analysis of... Read more.
GRAIL and University of Oxford to Present Long-Term Data From the SYMPLIFY Study Evaluating the Galleri® Multi-Cancer Early Detection Test in Symptomatic Individuals at the Early Detection of Cancer Conference (EDCC)
One-Third of Participants Initially Believed to Have a False-Positive Result Were Later Diagnosed With Cancer During Follow Up Updated Positive Predictive Value... Read more.